Pfizer Inc and Sermo, the largest online physician community in the US, have announced a strategic collaboration designed to redefine the way physicians in the U.S. and the healthcare industry work together to improve patient care.
Quest Diagnostics announced recently that it has joined the National ePrescribing Patient Safety Initiative (NePSI), and will offer physicians access to its Care360 Physician Portal and results capabilities.
As pharma biggies like Ranbaxy and Dr Reddy
Mumbai-based Metropolis Health Services is in advanced talks to acquire a 60% stake in a London-based path lab chain.
Druggists and chemists across India have decided to get their fragmented retail business more organised in order to check the incresing presence of MNCs in the domestic market.
Sidney Taurel, CEO, Eli Lilly and Company called on the health care industry, medical community and U.S. government to work on a health information technology system to provide rapid and useful insights on the effectiveness of medicines while improving drug safety.
A clinical research firm Veeda Clinical Research Pvt. Ltd is proposing a project, wherein it will adopt about a dozen cancer hospitals in tier-II and tier-III cities across India to ensure easy access to a wider patient pool for its drug test projects.
After recently acquiring 100 per cent stake in the animal healthcare joint venture (JV) company
Accenture and the Bristol-Myers Squibb Company have together launched the pharmaceutical industry’s first ‘pharmacovigilance’ center, in Chennai, India, to monitor safety of data collected on medicines.
It has come to the notice that despite the presence of a patent law that guards against giving exclusive commercial rights for modifications of existing medicines, research firms, both multinational and domestic, have tried their luck on 80 patent applications on TB drugs pending with Indian patent offices across the country.
The European Parliament will be demanding for funds to creation of a generic drugs industry in poor countries as the long-term solution to the developing world’s health crisis.
The Drug Information Centre (DIC) of Maharashtra State Pharmacy Council (MSPC), India is planning to launch the second phase of its interactive CD series with drug interaction information on anti ritrovirals (ARVs), anti virals and anti-TB drugs.